ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,050,000 | +34.2% | 500,000 | +4.1% | 1.46% | +44.5% |
| Q4 2016 | $7,491,000 | +19.5% | 480,501 | 0.0% | 1.01% | +46.0% |
| Q3 2016 | $6,271,000 | +90.5% | 480,501 | 0.0% | 0.69% | +48.2% |
| Q2 2016 | $3,291,000 | -26.7% | 480,501 | +1.2% | 0.47% | -30.9% |
| Q1 2016 | $4,489,000 | +25.0% | 475,035 | +33.2% | 0.68% | +57.2% |
| Q4 2015 | $3,591,000 | -29.6% | 356,600 | 0.0% | 0.43% | -47.2% |
| Q3 2015 | $5,103,000 | – | 356,600 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |